Cannabinoids: What PCPs Need to Know to Keep Patients Safe

As cannabis products become increasingly popular and gain legality throughout the United States, it can be confusing to understand the difference between those your patient can purchase at the corner store vs. FDA-approved products. This webcast will explain those distinctions as well as discuss safety concerns with the use of cannabis products. 

Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/11/2020 and they are subject to change as new information is published.

Learning Objectives

  • Outline the differences between pharmaceutically derived cannabinoids and products that do not undergo FDA review
  • Discuss safety considerations associated with cannabinoids, including interaction with other drugs

Additional Information

Partner: 
Pri-Med
State Approved: 
District of Columbia
Course summary
Available credit: 
  • 0.36 AANP Pharmacology Contact Hours
  • 0.25 MOC
  • 0.25 AMA PRA Category 1 Credit™
Course opens: 
12/14/2020
Course expires: 
12/14/2021
Rating: 
0

Michelle H. Cameron, MD, PT, MCR

Associate Professor
Department of Neurology
Oregon Health & Science University

Timothy Fong, MD

Professor of Psychiatry 
Director, UCLA Addiction Psychiatry Fellowship 
Steering Committee
UCLA Cannabis Research Initiative

Disclosures

The following financial relationships have been disclosed by faculty.

Michelle H. Cameron, MD, PT, MCR: Consultant for Greenwich Biosciences, Inc.
Timothy Fong, MD: No relevant financial relationships disclosed.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Designation Statement

Pri-Med Institute designates this endured material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308. 

Designation Statement

This program has been approved for 0.36 contact hour of continuing education, which includes 0.36 hour of pharmacology.

Available Credit

  • 0.36 AANP Pharmacology Contact Hours
  • 0.25 MOC
  • 0.25 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through Pri-Med. 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!

 

Topics

Pharmacology